Pharmaceutical Industry Manufacturing Trend for Tablet Dosage Forms and Opportunities for the Future: A Case Study of Current Practice and Future Developments
Faculty Mentor
Ahomed Abu Fayyad
Major/Area of Research
Pharmacy, Industrial Pharmacy
Description
INTRODUCTION: Tablet dosage forms remain the most widely utilized oral drug delivery system due to their stability, ease of administration, cost-effectiveness, and scalability. Over recent decades, advancements such as high-speed compression, improved granulation techniques, and regulatory frameworks (bioavailability, validation, and quality assurance) have significantly shaped modern pharmaceutical manufacturing. However, current systems remain largely semi-automated and resource-intensive, highlighting the need for technological transformation.
METHOD: This study presents a case-based evaluation of a contemporary pharmaceutical tablet manufacturing facility. The analysis maps the complete production workflow, including material handling, dispensing, granulation, lubrication, compression, coating, inspection, and packaging. Operational practices were reviewed alongside quality control (QC), quality assurance (QA), and documentation procedures. Furthermore, emerging technologies such as artificial intelligence (AI), automated guided vehicles (AGVs), and robotic systems were assessed for their potential integration into future manufacturing environments.
RESULTS: The current manufacturing process involves multiple interdependent departments and significant human intervention at each stage, ensuring compliance with regulatory and quality standards. Critical steps such as granulation, compression, and coating require continuous monitoring and in-process testing. The study identifies inefficiencies related to manual handling, energy consumption, and risk of human error. Future-oriented models demonstrate that automation using AI-driven systems, robotic arms, and real-time data monitoring can streamline operations, improve precision, reduce waste, and enhance production efficiency while maintaining stringent quality standards.
DISCUSSION/CONCLUSION: Tablet manufacturing is evolving from labor-intensive processes toward highly automated, intelligent systems. While initial implementation challenges such as system calibration and integration exist, long-term benefits include consistent product quality, reduced operational costs, and continuous production capabilities. Automation is expected to redefine workforce roles, shifting demand toward technical expertise in robotics, data analytics, and system maintenance. Despite technological advancements, human oversight—particularly in QA—will remain essential. This transition presents significant opportunities for innovation, sustainability, and efficiency in the pharmaceutical industry.
Pharmaceutical Industry Manufacturing Trend for Tablet Dosage Forms and Opportunities for the Future: A Case Study of Current Practice and Future Developments
INTRODUCTION: Tablet dosage forms remain the most widely utilized oral drug delivery system due to their stability, ease of administration, cost-effectiveness, and scalability. Over recent decades, advancements such as high-speed compression, improved granulation techniques, and regulatory frameworks (bioavailability, validation, and quality assurance) have significantly shaped modern pharmaceutical manufacturing. However, current systems remain largely semi-automated and resource-intensive, highlighting the need for technological transformation.
METHOD: This study presents a case-based evaluation of a contemporary pharmaceutical tablet manufacturing facility. The analysis maps the complete production workflow, including material handling, dispensing, granulation, lubrication, compression, coating, inspection, and packaging. Operational practices were reviewed alongside quality control (QC), quality assurance (QA), and documentation procedures. Furthermore, emerging technologies such as artificial intelligence (AI), automated guided vehicles (AGVs), and robotic systems were assessed for their potential integration into future manufacturing environments.
RESULTS: The current manufacturing process involves multiple interdependent departments and significant human intervention at each stage, ensuring compliance with regulatory and quality standards. Critical steps such as granulation, compression, and coating require continuous monitoring and in-process testing. The study identifies inefficiencies related to manual handling, energy consumption, and risk of human error. Future-oriented models demonstrate that automation using AI-driven systems, robotic arms, and real-time data monitoring can streamline operations, improve precision, reduce waste, and enhance production efficiency while maintaining stringent quality standards.
DISCUSSION/CONCLUSION: Tablet manufacturing is evolving from labor-intensive processes toward highly automated, intelligent systems. While initial implementation challenges such as system calibration and integration exist, long-term benefits include consistent product quality, reduced operational costs, and continuous production capabilities. Automation is expected to redefine workforce roles, shifting demand toward technical expertise in robotics, data analytics, and system maintenance. Despite technological advancements, human oversight—particularly in QA—will remain essential. This transition presents significant opportunities for innovation, sustainability, and efficiency in the pharmaceutical industry.